| Dr Imari Greaves, AUD | |
|
11201 Benton St Bldg 30, Loma Linda, CA 92357-1000 | |
| (909) 825-7084 | |
| Not Available |
| Full Name | Dr Imari Greaves |
|---|---|
| Gender | Female |
| Speciality | Audiologist |
| Location | 11201 Benton St Bldg 30, Loma Linda, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1164903597 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | 4748 (Massachusetts) | Primary |
| 231H00000X | Audiologist | 002800 (New York) | Secondary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Imari Greaves, AUD 11201 Benton St Bldg 30, Loma Linda, CA 92357-1000 Ph: (909) 825-7084 | Dr Imari Greaves, AUD 11201 Benton St Bldg 30, Loma Linda, CA 92357-1000 Ph: (909) 825-7084 |
News Archive
Elsevier, a world-leading publisher of scientific, technical and medical information products and solutions, today announced the results of a new international study that demonstrates the value of the academic library to the institution in improving grant proposal and report writing and in helping researchers attract grant income. Of the 8 institutions participating from around the globe, 6 demonstrated a greater than one-to-one (1:1) return in grant funding, with results ranging from 15.54:1 to 0.64:1.
In the first systematic large-scale evaluation of the UK National Early Warning Risk Score (NEWS) 2 as a scoring system for predicting severe COVID-19 outcomes in patients, researchers at King's College London have found poor-to-moderate accuracy for identifying patients at risk of being transferred to intensive care units (ICUs) or dying after 14 days of hospitalization.
Plexxikon today announced that it has treated the first patient in a Phase 2 clinical trial in Hodgkin lymphoma with PLX3397. This novel agent is an oral, selective inhibitor that down-modulates two key cell types that are thought to mediate the progression of Hodgkin lymphoma tumors — macrophages and mast cells.
A research group supported by the National Institutes of Health (NIH) has uncovered a new route for attacking the human immunodeficiency virus (HIV) that may offer a way to circumvent problems with drug resistance. In findings published today in the online edition of the Proceedings of the National Academy of Sciences, the researchers report that they have blocked HIV infection in the test tube by inactivating a human protein expressed in key immune cells.
› Verified 1 days ago
Megan Satre, AU.D. Audiologist Medicare: Medicare Enrolled Practice Location: 11201 Benton St, Loma Linda, CA 92357 Phone: 909-825-7084 | |
Dr. Cynthia Frey, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 11234 Anderson St Rm 2586a, Loma Linda, CA 92354 Phone: 909-558-7884 | |
Ian Boyle, Audiologist Medicare: Not Enrolled in Medicare Practice Location: 11201 Benton St, Loma Linda, CA 92357 Phone: 909-825-7084 | |
Dr. Ian Benjamin Mertes, AU.D., PH.D. Audiologist Medicare: Not Enrolled in Medicare Practice Location: Va Loma Linda Healthcare System, 11201 Benton Street, Loma Linda, CA 92357 Phone: 909-825-7084 | |
Dr. Kelsey Samuelson, AU.D Audiologist Medicare: Not Enrolled in Medicare Practice Location: 11201 Benton St, Loma Linda, CA 92357 Phone: 909-825-7084 | |
Ashley Sol Chun, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 11201 Benton St Bldg 30, Loma Linda, CA 92357 Phone: 909-825-7084 |